EdiTy Therapeutics
Dor Shimon has been working in the scientific field since 2016. Dor began their career as a Research and Development Scientist at Vital Technologies Ltd., before moving on to their current role as Lab Operation Manager & Scientist at Edity Therapeutics in 2021.
Dor Shimon completed a Bachelor of Science in Biology, General at The Open University of Israel from 2014 to 2018. Dor then went on to pursue a Master of Science in Immunology at Tel Aviv University from 2019 to 2021.
This person is not in any offices
EdiTy Therapeutics
EdiTy Therapeutics is a biotechnology company that develops a gene-editing technology designed for in-vivo gene-editing of target cells.